AstraZeneca says trial breast cancer drug improves survival rates
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.
A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.
Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.
King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss,.
Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.
HQ Team February 24, 2025: Chinese virologists at the Wuhan Institute of Virology have found another bat coronavirus that carries the risk of.
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com